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spheroid models for photodynamic
therapy: strengths and opportunities
Conor L. Evans*
Wellman Center for Photomedicine, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA
Three dimensional, in vitro spheroid cultures offer considerable utility for the development
and testing of anticancer photodynamic therapy regimens. More complex than
monolayer cultures, three-dimensional spheroid systems replicate many of the important
cell-cell and cell-matrix interactions that modulate treatment response in vivo. Simple
enough to be grown by the thousands and small enough to be optically interrogated,
spheroid cultures lend themselves to high-content and high-throughput imaging
approaches. These advantages have enabled studies investigating photosensitizer
uptake, spatiotemporal patterns of therapeutic response, alterations in oxygen diffusion
and consumption during therapy, and the exploration of mechanisms that underlie
therapeutic synergy. The use of quantitative imaging methods, in particular, has
accelerated the pace of three-dimensional in vitro photodynamic therapy studies,
enabling the rapid compilation of multiple treatment response parameters in a single
experiment. Improvements in model cultures, the creation of new molecular probes
of cell state and function, and innovations in imaging toolkits will be important for the
advancement of spheroid culture systems for future photodynamic therapy studies.
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1. Introduction
Optical imaging has enjoyed considerable success in supporting investigations into the myriad of
effects induced by anti-neoplastic therapies. From tracking cytotoxic effects induced by chemother-
apy [1] to measuring the normalization of blood vessels by vascular endothelial growth factor
(VEGF) blockade [2], optical imaging tools have provided quantitative metrics of therapeutic out-
comes on the tumoral, cellular, and subcellular scales. In studies of photodynamic therapy, optical
tools have been particularly useful in vivo, with the ability to measure not only treatment response
but also the three-dimensional uptake of photosensitizers and the location and rate of photo-
bleaching to assess therapeutic efficacy [3]. However, not all tumors lend themselves to optical
assessment; only select tumor types can be visualized in clinical settings, and only a handful of
cancer types are compatible with window-type methods in animal models [4]. Particularly prob-
lematic are metastatic diseases of the peritoneal cavity, including colorectal, ovarian, and pancreatic
cancer, which are difficult to visually assess for treatment planning and therapeutic efficacy studies.
Monolayer cultures, while useful for studying treatment effects, are too simple to replicate themany
heterogeneous treatment effects found in vivo.
Three dimensional tumor models partially address these limitations, enabling long-term stud-
ies of unique model tumors and individual cells over time. The 3D model environment can
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be advantageous for treatment studies, as many environmen-
tal variables can be controlled and adjusted (e.g., oxygena-
tion, pH) as compared to animal models. Spheroid cultures,
in particular, are unique systems that replicate many of the
features found within tumors in vivo, including cell-cell and cell-
matrix interactions. 3D spheroid cultures can grow to recapit-
ulate microenvironmental conditions including the deposition
of extracellular matrix, cellular polarization, steep oxygen gra-
dients, acidosis, hypoxia and necrotic cores. These models also
offer the advantage of history: they have been in development
and use since the 1970’s, when nodular cultures were grown
in spinner flasks that allowed individual tumor cells to clus-
ter into suspended nodules [5]. Since then, numerous biologi-
cal and technological advances have been made, enabling more
advanced suspension cultures, agar culture systems, cultures
based on extracellular matrix deposition, matrigel 3D cultures,
hanging drop methods, and synthetic matrix-based cultures [6–
10]. While many multicellular spheroids are monocultures, co-
culture spheroids have seen extensive use and can model aspects
of tumor heterogeneity. With thousands of studies utilizing 3D
in vitro models, it is possible to select optimal model systems for
any given study.
These features, while useful for general therapeutic experi-
ments, are of particular help in optimizing photodynamic therapy
(PDT): as many photosensitizers are fluorescent, optical imaging
can be employed to dynamically visualize the uptake and localiza-
tion of these agents at the cellular and subcellular level. Treatment
response, including photobleaching, apoptosis, and necrosis can
be tracked in real-time, with spatiospecific monitoring providing
links between microenvironmental variables and treatment out-
come. In addition, by taking advantage of the high-throughput
nature of optical imaging, many thousands of model tumors can
be studied in a single experiment, which can allow studies to
assess the effect of heterogeneity on treatment outcome.
2. Spheroid Model Systems for PDT
Spheroid cultures have served photodynamic research for nearly
three decades, [11, 12] with the majority of studies utilizing the
3D in vitro model systems to examine the uptake and thera-
peutic efficacy of photosensitizers. As it is outside the scope of
this minireview to cover every spheroid PDT experiment, a sub-
set of studies focused on imaging-based methods will be used to
illustrate the key utilities of 3D spheroid models.
2.1. Capturing PDT Outcomes with High-Content,
High Throughput Imaging Toolkits
One of the major strengths of 3D in vitro cultures is the abil-
ity to simultaneously grow, monitor, and treat many thou-
sands of individual tumor spheroids in a single experiment. As
spheroids can be heterogeneous in size, shape, and a host of
other factors, large-scale studies across thousands of spheroids
can reveal patterns of response, rare events, and important
subpopulations. Early studies utilizing spheroids at the Beck-
man Laser Institute, for example, examined the efficacy of
5-aminolevulinic acid/protoporphyrin IX (ALA/PpIX)-PDT by
observing the growth and survival of spheroids following treat-
ment [13–15]. In a study by Hirshberg et al. the effect of different
ALA derivatives on the growth and photodynamic therapy out-
comes of glioma spheroids was investigated. By observing the
diameters and surviving fractions of a large number of spheroids,
it was found that the lipophilic esters of ALA, such as benzyl
and hexyl ALA, were considerably more effective due to their
enhanced uptake within the model tumor nodules [13]. Imaging
tools, such as wide field fluorescence and confocal fluorescence
microscopy, have more recently enabled the addition of high-
content data collection. Overlay model systems, where spheroids
all reside at the same depth in culture, have been particular use-
ful, as automated stages can be used to scan over large fields of
view and acquire mosaics of photosensitizer uptake and treat-
ment response. In a study by Celli et al., the Live/Dead stain was
applied to ovarian cancer spheroids grown in overlay to study
the effects of both carboplatin chemotherapy and benzoporphrin
derivative monoacid (BPD)-PDT [16]. Through the acquisition
of high-resolution, large area mosaics, this study found the car-
boplatin therapy was ineffective in killing cells within the center
of the model tumor nodules. BPD-PDT, on the other hand, was
found to be more uniformly effective through spheroids. Recent
advances by Celli, Hasan, and colleagues have developed this
high-content imaging toolkit to collect and model a far greater
set of treatment parameters [17, 18] to support next-generation
photodynamic therapy screening experiments (Figure 1).
High-content imaging tools can also be used to follow long-
term changes in 3D spheroid cultures over time, providing
insight into cell death processes, nodule unpacking, and treat-
ment resistance. Studies in glioma spheroid cultures examined
not only PDT efficacy, but also the effects of therapy on the
migratory and invasive behavior of individual glioma cells post-
treatment; it was observed that both ALA/PpIX and Photofrin
photodynamic therapy had the significant effect of suppressing
cell migration and invasion in 3D cultures [19, 20]. This reduc-
tion in migratory activity, which may be of importance in reduc-
ing glioma metastasis in vivo, was postulated by Hirshberg et al.
to arise from the inhibition of cell-matrix adhesion triggered by
PDT [21]. The spatial patterns of apoptosis and structural degra-
dation have additionally been mapped over time with imaging
toolkits to select more optimal treatment methods [22–24]. For
example, BPD-PDT was recently applied to small (<250 µm
diameter) and large (>250 µm diameter) 3D ovarian cancer
spheroids, with the treatment outcome mapped over the course
of several days with optical coherence tomography (OCT). While
small nodules were found to undergo widespread apoptosis, large
nodules were observed to have only peripheral cellular death and
continued to grow unabated [22].
2.2. Mapping Three-Dimensional Photosensitizer
Uptake
These spatial patterns of therapeutic efficacy can result from a
host of factors, including the uptake and localization of photo-
sentizers. 3D spheroid cultures, which simulate avascular tumors,
have been helpful inmodeling the uptake and penetration of pho-
tosensitizers through multiple cell layers. For example, studies
from the Beckman Laser Institute, focused on the photodynamic
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FIGURE 1 | High-throughput imaging methods can provide
quantitative insight into PDT treatment parameters and
outcomes. High-throughput imaging approaches, such as the method
described here by Glidden et al. [17] (reproduced with permission),
offer the means to screen tens of thousands of individual tumor
nodules and their treatment response parameters in a single
experiment. For example, by monitoring the change in photosensitizer
fluorescence (“Change in PS” column), one can monitor photosensitizer
photobleaching to infer and correlate photosensitizer activity with
therapeutic outcome.
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FIGURE 2 | Physical sectioning and fluorescence microscopy can show
the uptake and localization patterns of photosensitizers with 3D
spheroids. An advantage of spheroid cultures is the ease with which they can
be manipulated so as to examine the microscale patterns of photosensitizer
uptake. In this figure reproduced from Klein et al. [29], OVCAR5 spheroids were
incubated with EtNBS and several of its derivatives for 4.5 h prior to being frozen
and sliced into thin sections. These sections can be readily imaged by confocal
microscopy to visualize the differential uptake of the compounds. (A) EtNBS, (B)
EtNBS-OH, (C) EtNBS-COOH, and (D) EtNBS-NH2. (E) Two-photon image of a
pimodinazole-stained 3D tumor nodule shown here in false color to visualize
hypoxic tumor cells contained inside the large nodules. Reprinted with
permission from [29]. Copyright 2012 American Chemical Society.
therapy of glioma, have utilized spheroid cultures to explore
the uptake and localization of ALA/PpIX-based regimens [25,
26]. Using confocal microscopy, Bigelow et al. similarly inves-
tigated the distribution of PpIX in multicellular spherods [27].
Xiao et al., using a spheroid bladder cancer model, examined
the uptake distributions of several porphyrin photosensitizers
using confocal microscopy. Like other investigations examining
porphyrin-based photosensitizers, each molecule was found to
localize primarily on the exterior of individual nodules. Interest-
ingly, though both free and liposomal formulations of BPD-MA
and hypocrellin R2 (HBBA-R2) were found to localize to the
periphery of spheroids, the liposome-delivered photosensitizers
demonstrated nearly exclusive peripheral uptake [28]. A study
examining the uptake behavior of both the porphyrin BPD-MA
and the benzophenothiazinium dye EtNBS in ovarian cancer
3D spheroid cultures found that, while BPD-MA bound to the
periphery of nodules, EtNBS completely penetrated and local-
ized to the highly acidic center of spheroids. This advantageous
localization pattern likely arose from the cationic small molecule
nature of EtNBS, which enables its efficient diffusion toward
low pH gradients [23]. In a follow-up study investigating side
chain modifications of EtNBS, 3D ovarian cancer spheroid cul-
tures were used as a model platform to examine the uptake of a
small derivative library with confocal microscopy and traditional
frozen section preparation. Despite only small modifications to
the molecule’s side chain, alterations in charge and partition coef-
ficient were found to have major effects on the uptake of the
modified photosensitizers (Figure 2) [29].
2.3. Examining the Effects of Oxygenation on
Treatment Outcome
Spheroid cultures, in which cells are tightly packed into three-
dimensional layers of cells, serve as excellent models for measur-
ing the effects of oxygen diffusion and consumption, both during
normal growth and photodynamic therapy. Notably, many of the
first PDT spheroid studies were led by Tom Foster and his col-
leagues to investigate photosensitizer uptake, localization, and
oxygenation effects using combinations of standard imaging tools
and oxygen microelectrodes [30–33]. Interestingly, the use of
oxygen electrodes demonstrated that steep oxygen gradients exist
within spheroidal model tumors, which can have major effects of
PDT outcome. As there is an important interplay between oxy-
gen consumption and supply during PDT, this relationship was
investigated by exploring fluence-rate effects. The results of this
study showed that low fluence-rate PDT optimized the degree
of cell killing due to the greater relative abundance of oxygen
throughout therapy [34]. In a more detailed investigation of this
effect, oxygenation was both spatially and temporally mapped
using oxygen electrodes to determine oxygen diffusion and con-
sumption during Photofrin-PDT in EMT6 cell line spheroids
[35]. This oxygenation measurement toolkit was recently com-
bined with imaging by Mitra et al., where EMT6 spheroids were
utilized in an imaging study examining the efficacy of mTHPC
(Foscan) vs. Photofrin. By combining confocal microscopy to
measure the uptake and photobleaching of the photosensitizers
with oxygenation measurements tracking spheroid oxygen ten-
sion (pO2), this study gathered a set of experimental parame-
ters that were able to explain mTHPC’s enhanced efficacy over
Photofrin [36].
Similarly, in studies of ALA/PpIX therapy in glioma
spheroids, it was found that the majority of cell killing occurred
at the spheroid periphery for both 3 and 6 J/cm2 doses. As ALA
can readily penetrate throughout large (>250 µm) spheroids,
these effects were proposed to arise from depleted oxygen within
the spheroid cores, suggesting that low fluence or repetitive
PDT sessions would have greater effect in vivo [25, 26]. These
spheroid size-dependent effects were similarly observed by West
and colleagues in studies of human colon adenocarcinoma cul-
tures [37, 38]. Indeed, studies examining the utility of hyperox-
ygenation therapy on spheroid cultures found that higher pO2
levels improved the outcome of hypericin PDT [39–41].
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Hypoxia in the cores of ovarian cancer spheroids was imaged
using the 2-nitroimidazole pimodinazole, revealing that a sig-
nificant fraction of cells within a 3D spheroid can experience
oxygen levels less than 20 mmHg, even when the nodule’s diam-
eter is less than 200 µm (Figure 2). As would be expected, these
hypoxic regions also experienced severe acidosis, with extracel-
lular pH levels measured between 5 and 6. As expected, the out-
come of BPD-PDT to these cultures was found to have a strong
size-dependence, with larger nodules experiencing reduced cell
killing. These studies suggested that photosensitizers capable of
Type-I photochemistry may have advantages within the oxygen-
depleted spheroid cores. Two studiesmaking use of EtNBS and its
derivatives, which operate predominantly through Type-I pho-
totoxicity, found that the cores of large, hypoxic nodules could
be effectively eliminated even at low light doses [23, 29]. When
EtNBS-PDT was applied to nodule cultures, an inverse size-
dependence was observed, with larger spheroids experiencing
greater therapeutic efficacy [23].
2.4. Screening for Combination Regimens
3D spheroid cultures serve as outstanding test beds to examine
potential interactions between therapeutics, with the potential
to examine not only arrays of different combination of thera-
pies, but also their order and timing. In a study by Hirschberg
et al., ALA-PDTwas combined with hyperthermia to examine for
potential synergism [42]. Interestingly, hyperthermia below 49◦C
was found to have minimal effects in 3D cultures, even though
lower temperatures (44◦C) were found effective in 2Dmonolayer
cell cultures; this greater resistance to temperature was thought
to be the likely result of cell-cell contacts providing pro-survival
signals. However, when hyperthermia was combined with PDT,
significant synergism was observed. The timing of PDTwas addi-
tionally found to be important: PDT and hyperthermia were
found to have a significant degree of interaction when applied
concurrently; this synergy was lost when PDT was applied 24 h
later. While this combination method was found to be synergis-
tic and cause apoptosis, the effect was not widespread and was
limited to the periphery of spheroids, likely due to low levels of
oxygenation deeper within the model tumors. The same group
additionally investigated the potential for synergy between ALA-
PDT and radiotherapy. While synergy was observed between
PDT and gamma irradiation, significant interactions were found
only under low light fluence levels. Unlike in the case of hyper-
thermia, the timing of the two therapies was not found to have an
influence [15]. An interesting study exploring the interaction of
haematoporphyrin derivative (HpD) with verapamil, a calcium
channel blocker, observed that the small molecule improved the
overall efficacy of PDT in colorectal cancer spheroids. This bene-
ficial interaction was hypothesized to arise from verapamil’s abil-
ity to hamper cellular eﬄux pumps, thus increasing intracellular
concentrations of the photosensitizer [43].
A more recent study led by Rizvi et al. utilized high-content
imaging assays to explore the combination regiment of carbo-
platin chemotherapy with BPD-PDT [44]. Carboplatin on its own
had previously been found to induce only peripheral cell killing in
spheroids, [16] an observation that was thought to arise from the
limited penetration of the platinum agent [45]. However, when
carboplatin was administered following PDT, the chemotherapy
drug was significantly synergistic, leading to widespread cell
death in ovarian cancer spheroid cultures. Interestingly, when
the order of administration was reversed, no synergism could
be observed. Confocal imaging of spheroids treated with BPD-
PDT revealed a pattern of “unpacking”-type structural degrada-
tion, where individual spheroids were observed to have increased
space between adjacent cells. It was hypothesized that not only
did this unpacking lead to the enhanced uptake of carboplatin
into PDT-treated spheroids, but the structural change might have
also led to re-oxygenation of the spheroid core, enabling greater
platin therapeutic efficacy. AnOCT-based study of EtNBS deriva-
tives observed similar in vitro tumor nodule unpacking following
PDT, suggesting that the mechanism proposed by Hasan and col-
leagues might be a general approach to enhancing combination
treatments [24].
3. Limitations and Outlook
3D in vitro cultures have been highly useful tools for understand-
ing and optimizing photodynamic therapy for cancer. Imaging
tools, ranging from simple bright field to more advanced tomo-
graphic imaging tools continue to provide new insight into the
processes that underlie treatment response behaviors. Despite
these advances, newmethods for imaging-based quantification of
3D cultures are needed. Many of the imaging assessment meth-
ods used in 3D studies have significant limitations that likely lead
to under- or overestimation of PDT efficacy in some models. For
example, the Live/Dead staining kit is useful when applied to
small (< 250µmdiameter) spheroids, but suffers from poor pen-
etration and uptake once model tumor nodules grow too large.
The same effect has been observed for apoptosis markers, such
as ApoTrace, which can only penetrate a few cell layers deep
[23]. Without the ability to deliver cell fate reporters through-
out spheroids, it is impossible to quantitatively assess treatment
outcome. This uptake limitation is particularly problematic as
large spheroids contain hypoxic cores that are known to be unre-
sponsive to many therapies. The application of label-free imag-
ing methods, such as endogenous multiphotonmicroscopy, OCT
and photoacoustic tomography, may serve to address these issues
in the future [46].
Given the importance of oxygen to the success of most PDT
regimens, there is a significant need for improved methods of
oxygen quantification within spheroids to visualize, map, and
correlate microscale pO2 to treatment outcome. While technolo-
gies such as photoacoustic tomography are providing new insight
into blood oxygen saturation levels during PDT in vivo, [47] such
toolkits rely on the presence of blood and do not directly report
tissue oxygen levels. Recent efforts developing porphyrin den-
drimers capable of penetrating throughout 3D spheroid models
show much promise for future PDT studies, as oxygen concen-
tration can be mapped on the cellular level before, during, and
after treatment [48]. This approach will likely become more eas-
ily applied with the advent of new, brighter porphyrin oxygen
sensors.
The same simplicity that makes spheroid models useful also
can limit their predictive ability. 3D tumor spheroids are avas-
cular and only model uptake from the surrounding media or
embedding matrix. As such, they are not likely to be of help in
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understanding therapies that induce vascular shutdown or that
require the enhanced permeability and retention (EPR) effect
for uptake. For example, the ovarian cancer spheroids developed
by Hasan and colleagues are excellent at simulating small peri-
toneal metastases, but likely are not entirely informative in pre-
dicting PDT outcomes of vascularized metastatic lesions. More
advanced models, which incorporate blood vessel-like structures
are required to better assess such treatment approaches. A recent
study investigating the effect of flow in ovarian 3D cultures hints
at the promise of more advanced in vitro models [49]. Addi-
tionally, multicomponent spheroids, which incorporate cells such
as tumor associated fibroblasts or endothelial cells are likely to
play a role in simulating complex tumor microenvironments and
heterogeneity [50]. Ultimately, there is a need to carry out side-
by-side correlative studies directly comparing PDT outcomes
in spheroid cultures to those in animal models to examine the
predictive capability of in vitro cultures. This will be impor-
tant to carry out not only in immunocompromised cell-line and
patient-derived xenograft animal models, but also in immuno-
competent animals to assess the degree of immune system
involvement.
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